The managers of the National Medical Services Laboratories in Pennsylvania, USA, denied that Mohbad had undergone a toxicological test.
According to the Punch, the US laboratory failed to conduct any toxicology tests on site to determine the cause of singer Ilerioluwa Aloba, popularly known as Mohbad’s, death.
Punch contacted NMS Labs about the examination, and NMS Labs responded with this comment.
A pathologist said during the May 15 Coroner’s Court hearing that Mohbad’s body decomposed, making an autopsy difficult to determine the cause of death.
When the Coroner’s Court met again in the Ikorodu district in November 2023, state attorney O.
Akinde told the court that the toxicology test—which is an essential step in the autopsy process to determine the cause of death—was not available.
Three affiliate centers are helping the state DNA and Forensic Centre, which is now handling the case, but their services are limited.
“So, if there is an emergency like this one that we have, they will not say they cannot handle it. So, there are three of them in the US and the one handling this particular one is the NMS in Pennsylvania, USA,” Omotoso said during the live program.
Punch disclosed that an email was sent to the aforementioned lab to inquire about whether or not a toxicology test had been carried out at their establishment to ascertain Mohbad’s cause of death.
In response to the correspondence dated May 17, Esther Dede, a Client Services Associate in the Forensics Division of NMS Labs, denied that Mohbad’s toxicology test was carried out in any of their facilities, as stated by the state government.
“Unfortunately, we do not have a case for that patient. To maintain our compliance with HIPAA privacy regulations, we would need authorization from the submitting agency.”
Leave a Reply